Growth Metrics

Immuron (IMRN) Equity Average (2017 - 2025)

Immuron has reported Equity Average over the past 9 years, most recently at $6.0 million for Q2 2025.

  • For Q2 2025, Equity Average rose 40.51% year-over-year to $6.0 million; the TTM value through Jun 2025 reached $6.0 million, up 40.51%, while the annual FY2025 figure was $2.7 million, 74.72% down from the prior year.
  • Equity Average for Q2 2025 was $6.0 million at Immuron, up from $3.4 million in the prior quarter.
  • Over five years, Equity Average peaked at $15.7 million in Q4 2022 and troughed at $236775.3 in Q2 2022.
  • A 5-year average of $5.7 million and a median of $4.3 million in 2024 define the central range for Equity Average.
  • Biggest five-year swings in Equity Average: crashed 85.51% in 2021 and later soared 6160.13% in 2022.
  • Year by year, Equity Average stood at $250363.6 in 2021, then soared by 6160.13% to $15.7 million in 2022, then tumbled by 58.62% to $6.5 million in 2023, then plummeted by 46.9% to $3.4 million in 2024, then soared by 73.17% to $6.0 million in 2025.
  • Business Quant data shows Equity Average for IMRN at $6.0 million in Q2 2025, $3.4 million in Q4 2024, and $4.3 million in Q3 2024.